Sandra Swain

Sandra Swain

Director/Board Member at IMMUNOME, INC.

Net worth: - $ as of 30/06/2026

72 year
Consumer Services
Health Technology
Health Services

Profile

Sandra M.
Swain
is Director at Conquer Cancer Foundation of the American Society of Clinical since 2019.
Dr. Swain is Independent Director at Immunome, Inc. since 2024.
Dr. Swain is Professor & Associate Dean at Georgetown University Medical Center since 2016.
Dr. Swain is Vice President-Genetic Medicine at MedStar Health, Inc. since 2018.
Dr. Swain was Independent Director at Seagen, Inc. from 2022 to 2023.
Dr. Swain earned a doctorate from the University of Florida and completed undergraduate studies at The University of North Carolina at Charlotte.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/06/2026 0 ( -.--% ) - $ 30/06/2026

Sandra Swain active positions

CompaniesPositionStart
IMMUNOME, INC. Director/Board Member 25/04/2024
Director/Board Member 01/01/2007
Corporate Officer/Principal 01/06/2007
Corporate Officer/Principal 01/01/2018

Former positions of Sandra Swain

CompaniesPositionEnd
SEAGEN INC. Director/Board Member 14/12/2023
See the detail of Sandra Swain's experience

Training of Sandra Swain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Services

Consumer Services

Commercial Services

Consumer Services

Consumer Services